Celldex Therapeutics Inc
Atidarymo kaina
SektoriusSveikatos priežiūra
31.83 0.98
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
31.33
Max
32.16
Pajamos | 2.6M -79M |
|---|---|
Pardavimai | -60K 15K |
Pelnas, tenkantis vienai akcijai | -1.18 |
Pelno marža | -524,566.667 |
Darbuotojai | 198 |
EBITDA | -3M -84M |
Rekomendacijos | Stiprus pirkimas |
|---|---|
12 mėnesių prognozė | +59.09% upside |
Kitas uždarbis | 2026-08-05 |
|---|
Rinkos kapitalizacija | -330M 2.2B |
|---|---|
Ankstesnė atidarymo kaina | 30.85 |
Ankstesnė uždarymo kaina | 31.83 |
Naujienos nuotaikos
By Acuity
50%
50%
162 / 342 reitingas Healthcare
Celldex Therapeutics Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Celldex Therapeutics Inc
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
